Quest Diagnostics Ranked Among FORTUNE Magazine's 'World's Most Admired Companies' for Fourth Consecutive Year

MADISON, N.J., March 4, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that it has been included on FORTUNE magazine's "World's Most Admired Companies" list.  

Quest Diagnostics moved to second in the "Health Care" industry category of "Pharmacy and Other Services." The 2011 ranking is the fourth consecutive year that the company has been included on FORTUNE magazine's well-regarded reputation ranking of the world's corporations.

"We're pleased to again be recognized by FORTUNE magazine as among the world's most admired companies," said Surya N. Mohapatra, Ph.D., Chairman and CEO of Quest Diagnostics.  "This recognition reflects Quest Diagnostics unwavering commitment to our patients and our dedication to quality service and continuous innovation in diagnostics."

FORTUNE's list of Most Admired Companies is based on surveys of thousands of executives, directors and securities analysts based on nine criteria: innovation, people management, use of corporate assets, quality of management; social responsibility; financial soundness, long-term investment, quality of products and services, and global competitiveness.  The 2011 list ranks 350 companies.

The ranking for Quest Diagnostics may be found online at:

About Quest Diagnostics

Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at

Media Contact:  Glenn Brandow, +1-973-520-2800

SOURCE Quest Diagnostics Incorporated